September 22, 2023 Comments Off on New patent for Eyenovia drug MYDCOMBI Posted in: Patent Added Annual Drug Patent Expirations for MYDCOMBI Mydcombi is a drug marketed by Eyenovia and is included in one NDA. It is available from one supplier. The generic ingredient in MYDCOMBI…
The post New patent for Eyenovia drug MYDCOMBI appeared first on Drug…
September 22, 2023 Comments Off on New patent for Glaxosmithkline drug ZEJULA Posted in: Patent Added Annual Drug Patent Expirations for ZEJULA Zejula is a drug marketed by Glaxosmithkline and is included in two NDAs. It is available from one supplier. There are seven patents protecting…
The post New patent for Glaxosmithkline drug ZEJULA appeared firs…